Orbit Genomics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $15M

  • Investors
  • 11

Orbit Genomics General Information

Description

Developer of a genomic analysis platform designed to support the diagnosis, treatment, and prevention of complex diseases. The company offers genome-wide short tandem repeat analysis, ancestry- and gender-aware interpretation, and detection of repetitive deoxyribonucleic acid variations, enabling healthcare providers and researchers to identify and assess genetic conditions across diverse populations.

Contact Information

Website
www.orbitgenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4665 Nautilus Court South
  • Suite 300
  • Boulder, CO 80301
  • United States
+1 (720)
Primary Industry
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, FemTech, Life Sciences, Oncology
Corporate Office
  • 4665 Nautilus Court South
  • Suite 300
  • Boulder, CO 80301
  • United States
+1 (720)

Orbit Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orbit Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC $15M Upcoming Generating Revenue
11. Later Stage VC 03-Nov-2026 In Progress Generating Revenue
10. Mezzanine 31-Jul-2026 Completed Product Development
9. Mezzanine 28-Jul-2025 Completed Pre-Clinical Trials
8. Secondary Transaction - Private Completed Product In Beta Test
7. Grant 23-Sep-2024 Completed Product In Beta Test
6. Accelerator/Incubator 26-Feb-2024 Completed Product In Beta Test
5. Seed Round 06-Jan-2022 Completed Product Development
4. Grant 21-May-2021 $250K Completed Product Development
3. Accelerator/Incubator 01-Jan-2020 Completed Product Development
To view Orbit Genomics’s complete valuation and funding history, request access »

Orbit Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Orbit Genomics’s complete cap table history, request access »

Orbit Genomics Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Orbit Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025199499-A1 Methods and systems for sample classification Pending 22-Mar-2024
AU-2020260998-A1 Methods and systems for microsatellite analysis Inactive 22-Apr-2019
CA-3137720-A1 Methods and systems for microsatellite analysis Pending 22-Apr-2019
EP-3959341-A1 Methods and systems for microsatellite analysis Active 22-Apr-2019
EP-3959341-A4 Methods and systems for microsatellite analysis Active 22-Apr-2019 G16B40/20
To view Orbit Genomics’s complete patent history, request access »

Orbit Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orbit Genomics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
CancerX (USA) Accelerator/Incubator
New Horizon Health Corporation Minority
New Mexico Angels Angel Group Minority
NHH Ventures Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Orbit Genomics FAQs

  • When was Orbit Genomics founded?

    Orbit Genomics was founded in 2016.

  • Where is Orbit Genomics headquartered?

    Orbit Genomics is headquartered in Boulder, CO.

  • What is the size of Orbit Genomics?

    Orbit Genomics has 9 total employees.

  • What industry is Orbit Genomics in?

    Orbit Genomics’s primary industry is Biotechnology.

  • Is Orbit Genomics a private or public company?

    Orbit Genomics is a Private company.

  • What is Orbit Genomics’s current revenue?

    The current revenue for Orbit Genomics is .

  • How much funding has Orbit Genomics raised over time?

    Orbit Genomics has raised $4.3M.

  • Who are Orbit Genomics’s investors?

    National Institutes of Health, CancerX (USA), New Horizon Health, New Mexico Angels, and NHH Ventures are 5 of 11 investors who have invested in Orbit Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process